Skip to main content
SpringerLink
Log in

An evaluation of the partial dopamine agonist terguride regarding positive symptoms reduction in schizophrenics

  • Short Communication
  • Published:
Journal of Neural Transmission / General Section JNT Aims and scope Submit manuscript

Summary

Eleven schizophrenics (7 females) displaying an acute psychotic episode received the partial dopamine agonist terguride in doses up to 2 mg per day. Improvement in terms of positive symptoms reduction was observed in two cases only. In contrast, in a previous clinical trial targeted at negative schizophrenic symptoms, the majority of the patients appeared to have benefited from terguride application.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Andreasen NC (1983) The scale for the assessment of negative symptoms (SANS). The University of Iowa, Iowa City

    Google Scholar 

  • Arbeitsgemeinschaft für Methodik und Dokumentation in der Psychiatrie — AMDP (1979) Manual zur Dokumentation psychiatrischer Befunde, 3. Aufl. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Carlsson A (1983) Dopamine receptor agonists — intrinsic activity vs. state of receptor. J Neural Transm 57: 309–315

    Google Scholar 

  • Olbrich R, Schanz H (1988) The effect of the partial dopamine agonist terguride on negative symptoms in schizophrenics. Pharmacopsychiatry 21: 389–390

    Google Scholar 

  • Overall JE, Gorham DR (1976) BPRS. Brief psychiatric rating scale. In: Guy W (ed) ECDEU assessment manual for psychopharmacology, rev edn. Rockville, Maryland, pp 157–169

  • Wachtel H (1983) Central dopaminergic and antidopaminergic effects of ergot derivatives structurally related to lisuride. In: Calne DB, Horowski R, McDonald FJ, Wuttke W (eds) Lisuride and other dopamine agonists. Raven, New York, pp 109–125

    Google Scholar 

  • Wachtel H, Dorow R (1983) Dual action on central dopamine function of transdihydrolisuride, a 9,10-dihydrogenated analogue of the ergot dopamine agonist lisuride. Life Sci 32: 421–432

    Google Scholar 

Download references

Author information

Author notes

  1. R. Olbrich

    Present address: Central Institute of Mental Health, Mannheim, Federal Republic of Germany

Authors and Affiliations

  1. Central Institute of Mental Health, Mannheim, Federal Republic of Germany

    H. Schanz

Authors
  1. R. Olbrich
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Schanz
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Olbrich, R., Schanz, H. An evaluation of the partial dopamine agonist terguride regarding positive symptoms reduction in schizophrenics. J. Neural Transmission 84, 233–236 (1991). https://doi.org/10.1007/BF01244973

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01244973

Keywords

Search

Navigation